Global X Genomics & BiotechnGNOMETF
13F holders, Q4 2024 (December 31)2holders +1
1new positions
0sold out
$9.71avg. 13F price*
At the end of Q4 2024, 2 institutions reported holding Global X Genomics & Biotechn (GNOM) in their 13F filings, up 1 from Q3 2024. 1 opened new positions and 0 sold out. The largest holders were Raffa Wealth Management, LLC ($10K) and Pension & Wealth Management Advisors, Inc. ($4K).
- Company
- Global X Genomics & Biotechn
- CUSIP
- 37960A214
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $4K |
| Exits | 0 | $0 |
All 13F filers, Q3 2024 → Q4 2024: 384 shares bought, net +384 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 2 holders
| Raffa Wealth Management, LLC | 0.00% | No change | 1,007 | $10K |
| Pension & Wealth Management Advisors, Inc. | 0.00% | New | 384 | $4K |
"% of holder's portfolio" is GNOM's weight in each manager's 13F, not the share of Global X Genomics & Biotechn the manager owns.